Background & aims: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine natural history and prognostic factors using a large multicenter cohort of PSVD patients. Methods: Retrospective multicentric study of PSVD patients and signs of portal hypertension (PH) prospectively registered in 27 centers. Results: 587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patient had an associated condition, that was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients; ascites in 117 and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was of 15% at 5 years, with a 5-year rebleeding rate of 18%. Five-year cumulative incidence of new or worsening ascites was of 18% and of developing PVT of 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver related death. Transplant-free survival was 97%, and 83% at 1 and 5 years. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed the creation of a Nomogram that accurately predicted prognosis. Conclusions: Prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome / M. Magaz, H. Giudicelli-Lett, J. G Abraldes, O. Nicoară-Farcău, F. Turon, N. Rajoriya, A. Goel, K. Raymenants, S. Hillaire, L. Téllez, L. Elkrief, B. Procopet, L. Orts, F. Nery, A. Shukla, H. Larrue, H. Degroote, V. Aguilera, E. Llop, L. Turco, F. Indulti, S. Gioia, G. Tosetti, N. Bitto, C. Becchetti, E. Alvarado, C. Roig, R. Diaz, M. Praktiknjo, A. Konicek, P. Olivas, J.I. Fortea, H. Masnou, Á. Puente, A. Ardèvol, C.A. Navascués, M. Romero-Gutiérrez, B. Scheiner, G. Semmler, M. Mandorfer, F. Damião, A. Baiges, A. Ojeda, M. Simón-Talero, C. González-Alayón, A. Díaz, Á. García-Criado, A. De Gottardi, M. Hernández-Guerra, J. Genescà, N. Drilhon, C.N. Ferreira, T. Reiberger, M. Rodríguez, R.M. Morillas, J. Crespo, J. Trebicka, R. Bañares, C. Villanueva, A. Berzigotti, M. Primignani, V. La Mura, O. Riggio, F. Schepis, X. Verhelst, J.L. Calleja, C. Bureau, A. Albillos, F. Nevens, V. Hernández-Gea, D. Tripathi, P. Rautou, J.C. García-Pagán. - In: JOURNAL OF HEPATOLOGY. - ISSN 0168-8278. - (2024), pp. 1-13. [Epub ahead of print] [10.1016/j.jhep.2024.07.035]
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome
G. TosettiPrimo
;N. BittoPenultimo
;V. La MuraUltimo
;
2024
Abstract
Background & aims: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine natural history and prognostic factors using a large multicenter cohort of PSVD patients. Methods: Retrospective multicentric study of PSVD patients and signs of portal hypertension (PH) prospectively registered in 27 centers. Results: 587 patients were included, median age of 47 years and 38% were women. Four-hundred and one patient had an associated condition, that was graded as severe in 157. Median follow-up was 68 months. At diagnosis, 64% of patients were asymptomatic while 36% had a PH-related complication: PH-related bleeding in 112 patients; ascites in 117 and hepatic encephalopathy in 11. In those not presenting with bleeding, the incidence of first bleeding was of 15% at 5 years, with a 5-year rebleeding rate of 18%. Five-year cumulative incidence of new or worsening ascites was of 18% and of developing PVT of 16%. Fifty (8.5%) patients received a liver transplantation and 109 (19%) died, including 55 non-liver related death. Transplant-free survival was 97%, and 83% at 1 and 5 years. Variables independently associated with transplant-free survival were age, ascites, serum bilirubin, albumin and creatinine levels at diagnosis and severe associated conditions. This allowed the creation of a Nomogram that accurately predicted prognosis. Conclusions: Prognosis of PSVD is strongly determined by the severity of the associated underlying conditions and parameters of liver and renal function.File | Dimensione | Formato | |
---|---|---|---|
VALDIG PSVD Marta Magaz_JHEP 2024.pdf
embargo fino al 22/08/2025
Tipologia:
Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione
3.49 MB
Formato
Adobe PDF
|
3.49 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
1-s2.0-S0168827824024814-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
961.01 kB
Formato
Adobe PDF
|
961.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.